H. Aronen, J. Glass, F. Pardo, J. Belliveau, M. Gruber et al., Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility, Acta Radiol, vol.36, pp.520-528, 1995.

N. Akella, D. Twieg, T. Mikkelsen, F. Hochberg, S. Grossman et al., Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: Quality and analysis results of a phase I trial, Journal of Magnetic Resonance Imaging, vol.15, issue.6, pp.913-922, 2004.
DOI : 10.1002/jmri.20202

S. Cha, E. Knopp, G. Johnson, A. Litt, J. Glass et al., Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin, AJNR Am J Neuroradiol, vol.21, pp.881-890, 2000.

L. Ostergaard, F. Hochberg, J. Rabinov, A. Sorensen, L. M. Kim et al., Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors, Journal of Neurosurgery, vol.90, issue.2, pp.300-305, 1999.
DOI : 10.3171/jns.1999.90.2.0300

A. Perles-barbacaru and H. Lahrech, Method, Journal of Cerebral Blood Flow & Metabolism, vol.6, issue.3, pp.618-631, 2007.
DOI : 10.1016/S0006-3495(93)81441-3

URL : https://hal.archives-ouvertes.fr/inserm-00381751

H. Lahrech, A. Perles-barbacaru, S. Aous, L. Bas, J. Debouzy et al., Cerebral Blood Volume Quantification in a C6 Tumor Model Using Gadolinium per (3,6-Anhydro) ??-Cyclodextrin as a New Magnetic Resonance Imaging Preclinical Contrast Agent, Journal of Cerebral Blood Flow & Metabolism, vol.8, issue.5, pp.1017-1029, 2008.
DOI : 10.1002/mrm.1910360511

URL : https://hal.archives-ouvertes.fr/inserm-00381358

A. Perles-barbacaru, B. Van-der-sanden, R. Farion, and H. Lahrech, How Stereological Analysis of Vascular Morphology Can Quantify the Blood Volume Fraction as a Marker for Tumor Vasculature: Comparison with Magnetic Resonance Imaging, Journal of Cerebral Blood Flow & Metabolism, vol.51, issue.3, pp.489-501, 2012.
DOI : 10.1002/mrm.10660

URL : https://hal.archives-ouvertes.fr/inserm-00726960

V. Kiselev, Transverse relaxation effect of MRI contrast agents: A crucial issue for quantitative measurements of cerebral perfusion, Journal of Magnetic Resonance Imaging, vol.34, issue.6, pp.693-696, 2005.
DOI : 10.1002/jmri.20452

A. Pathak, S. Rand, and K. Schmainda, The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (?R2*) and contrast agent (MION) dose, Journal of Magnetic Resonance Imaging, vol.46, issue.4, pp.397-403, 2003.
DOI : 10.1002/jmri.10371

K. Kuppusamy, W. Lin, G. Cizek, and E. Haacke, In vivo regional cerebral blood volume: quantitative assessment with 3D T1-weighted pre- and postcontrast MR imaging., Radiology, vol.201, issue.1, pp.106-112, 1996.
DOI : 10.1148/radiology.201.1.8816529

W. Lin, R. Paczynski, K. Kuppusamy, C. Hsu, and E. Haacke, Quantitative measurements of regional cerebral blood volume using MRI in rats: Effects of arterial carbon dioxide tension and mannitol, Magnetic Resonance in Medicine, vol.59, issue.3, pp.420-428, 1997.
DOI : 10.1002/mrm.1910380311

C. Schwarzbauer, J. Syha, and A. Haase, Quantification of regional blood volumes by rapidT1 mapping, Magnetic Resonance in Medicine, vol.714, issue.5, pp.709-712, 1993.
DOI : 10.1002/mrm.1910290521

A. Villringer, B. Rosen, J. Belliveau, J. Ackerman, R. Lauffer et al., Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects, Magnetic Resonance in Medicine, vol.7, issue.2, pp.164-174, 1988.
DOI : 10.1002/mrm.1910060205

H. Moreno, F. Hua, T. Brown, and S. Small, Longitudinal mapping of mouse cerebral blood volume with MRI, NMR in Biomedicine, vol.9, issue.5, pp.535-543, 2006.
DOI : 10.1002/nbm.1022

H. Moreno, W. Wu, T. Lee, A. Brickman, R. Mayeux et al., Imaging the A??-Related Neurotoxicity of Alzheimer Disease, Archives of Neurology, vol.64, issue.10, pp.1467-1477, 2007.
DOI : 10.1001/archneur.64.10.1467

C. Weidensteiner, F. Metzger, A. Bruns, B. Bohrmann, B. Kuennecke et al., Cortical hypoperfusion in the B6.PS2APP mouse model for Alzheimer's disease: Comprehensive phenotyping of vascular and tissular parameters by MRI, Magnetic Resonance in Medicine, vol.55, issue.1, pp.35-45, 2009.
DOI : 10.1002/mrm.21985

E. Wu, H. Tang, T. Asai, and S. Yan, Regional cerebral blood volume reduction in transgenic mutant APP (V717F, K670N/M671L) mice, Neuroscience Letters, vol.365, issue.3, pp.223-227, 2004.
DOI : 10.1016/j.neulet.2004.05.004

E. Wu, K. Wong, M. Andrassy, and H. Tang, High-resolution in vivo CBV mapping with MRI in wild-type mice, Magnetic Resonance in Medicine, vol.40, issue.4, pp.765-770, 2003.
DOI : 10.1002/mrm.10425

J. Lee, M. Garwood, R. Menon, G. Adriany, P. Andersen et al., High contrast and fast three-dimensional magnetic resonance imaging at high fields, Magnetic Resonance in Medicine, vol.21, issue.3, pp.308-312, 1995.
DOI : 10.1002/mrm.1910340305

K. Ugurbil, M. Garwood, J. Ellermann, K. Hendrich, R. Hinke et al., Imaging at high magnetic fields: initial experiences at 4 T, Magn Reson Q, vol.9, pp.259-277, 1993.

M. Firbank, A. Coulthard, R. Harrison, and E. Williams, A comparison of two methods for measuring the signal to noise ratio on MR images, Physics in Medicine and Biology, vol.44, issue.12, pp.261-264, 1999.
DOI : 10.1088/0031-9155/44/12/403

R. De-graaf, P. Brown, S. Mcintyre, T. Nixon, K. Behar et al., High magnetic field water and metabolite protonT1 andT2 relaxation in rat brain in vivo, Magnetic Resonance in Medicine, vol.49, issue.2, pp.386-394, 2006.
DOI : 10.1002/mrm.20946

Y. Seo, A. Takamata, T. Ogino, H. Morita, S. Nakamura et al., H magnetic resonance imaging, The Journal of Physiology, vol.2, issue.1, pp.217-228, 2002.
DOI : 10.1113/jphysiol.2002.027227

S. Miraux, P. Massot, E. Ribot, J. Franconi, and E. Thiaudiere, 3D TrueFISP imaging of mouse brain at 4.7T and 9.4T, Journal of Magnetic Resonance Imaging, vol.50, issue.2, pp.497-503, 2008.
DOI : 10.1002/jmri.21449

F. Bourasset, M. Ouellet, C. Tremblay, C. Julien, T. Do et al., Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease, Neuropharmacology, vol.56, issue.4, pp.808-813, 2009.
DOI : 10.1016/j.neuropharm.2009.01.006

P. Verant, R. Serduc, B. Van-der-sanden, C. Remy, and J. Vial, A Direct Method for Measuring Mouse Capillary Cortical Blood Volume Using Multiphoton Laser Scanning Microscopy, Journal of Cerebral Blood Flow & Metabolism, vol.36, issue.5, pp.1072-1081, 2007.
DOI : 10.1371/journal.pbio.0040022

URL : https://hal.archives-ouvertes.fr/inserm-00381768

D. Morton, M. Jennings, A. Buckwell, R. Ewbank, C. Godfrey et al., Refining procedures for the administration of substances British Veterinary Association Animal Welfare Foundation/Fund for the Replacement of Animals in Medical Experiments, UFAW Joint Working Group on Refinement, pp.1-41, 2001.

T. Perles-barbacaru, D. Procissi, A. Demyanenko, and R. Jacobs, Quantitative pharmacologic MRI in mice, NMR in Biomedicine, vol.7, issue.2, pp.498-505, 2012.
DOI : 10.1002/nbm.1760